EZR and Patent ductus arteriosus: Autoantibodies against Ezrin appeared to be particularly important as diagnostic tools, because their presence has been demonstrated in a pre-diagnostic cohort of patients and at the early stage of disease in two genetically engineered mouse models (GEM) of PDA [12].